IODOSORB

CE medical device. Antiseptic dressing based on cadexomer technology: absorbs exudates and releases iodine in a controlled manner.
Indicated for the local treatment of chronic exuding wounds. IODOSORB can be used under compression therapy. IODOSORB can be used on infected wounds. When the product is used on infected wounds.

How to use
Application
Wash your hands thoroughly before and after application. After putting on gloves, clean the wound and the perilesional area with a gentle stream of water or saline solution. Do not dry the wound surface. Remove the impregnated gauze from both sides of the single-dose paste or open the package (sachet or aluminum tube). Conform the dressing to the wound surface. Cover the lesion completely with an appropriate secondary dressing. Apply a compression bandage, where indicated.
Dressing change
IODOSORB should be changed when it is saturated with exudate and has released all the iodine. This is indicated by loss of color, usually two or three times a week. If the wound is heavily exuding, it may be necessary to change the dressing daily. If necessary, moisten residues for a few minutes before removing them. Gently remove IODOSORB using a stream of water or saline solution. Before reapplying IODOSORB, gently absorb any excess fluid, leaving the wound surface slightly moist.

Warnings
There is a potential risk of interaction with lithium, resulting in an increased likelihood of hypothyroidism. Do not use IODOSORB concomitantly with mercurial antiseptics or with taurolidine. Be aware of any interference with thyroid function indices in case of diagnostic thyroid tests.

Contraindications
IODOSORB should not be used on dry necrosis, or in patients with known hypersensitivity to iodine or any of its components. Do not use IODOSORB in pediatric age, during pregnancy or breastfeeding, or in people with thyroid or kidney function disorders (e.g., Hashimoto's thyroiditis or non-toxic nodular goiter).

Precautions for use
The contents of the single package must be used for one patient only. Do not use IODOSORB near eyes, ears, nose or mouth. The product is for external use only. In the first hour after application, IODOSORB may cause mild and transient pain. This indicates that the product is beginning to cleanse the wound. Occasionally, IODOSORB may cause swelling or redness of the perilesional skin. This effect is usually transient. Contact of the product with perilesional skin or intact skin should be minimized. When IODOSORB is allowed to dry, an adherent crust may form.

Format
7 sachets of 3 g microgranules.

Code 66001286